Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.

International journal of clinical and experimental pathology - 1 Jan 2014

Kim Ho-Cheol, Song Joon Seon, Lee Jae Cheol, Lee Dae Ho, Kim Sang-We, Lee Jung-Shin, Kim Woo Sung, Rho Jin Kyung, Kim Sun Ye, Choi Chang-Min

Abstract excerpt

BACKGROUND: Small cell lung cancer (SCLC) is one of highly aggressive cancers with poor prognosis. Unfortunately, there are as yet no molecular targets that can be exploited to prolong survival in patients with SCLC. This study aimed to investigate possible molecular markers associated with prognosis in limited-stage small cell lung cancer (LS-SCLC). METHODS: The demographic and clinical data for LS-SCLC patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to L-Lactate Dehydrogenase
Share to NAD(P)H Dehydrogenase (Quinone)

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Poly (ADP-Ribose) Polymerase-1

Share to Poly(ADP-ribose) Polymerases

Share to Proportional Hazards Models

Share to Small Cell Lung Carcinoma

Share to Superoxide Dismutase

Share to Tertiary Care Centers

Source

Open in PubMed Open full text

Identifiers

PMID: 25400754
PMCID: PMC4230145

Genes

PARP1
NQO1
SOD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.PMID 25400754Read ↗

Genomic Features of Chinese Small Cell Lung CancerSemantic proximity Read ↗

PARP inhibitors in small cell lung cancer: The underlying mechanisms and clinical implicationsSemantic proximity Read ↗

Genomic features of Chinese small cell lung cancer.Semantic proximity Read ↗

Association of PARP1-specific polymorphisms and haplotypes with non-small cell lung cancer subtypes.Semantic proximity Read ↗

MicroRNA-related polymorphisms in apoptosis pathway genes are predictive of clinical outcome in patients with limited disease small cell lung cancer.Semantic proximity Read ↗

Polymorphisms of the PD-L1 gene 3'-untranslated region are associated with the expression of PD-L1 in non-small cell lung cancer.Semantic proximity Read ↗

Association of Base Excision Repair Gene Polymorphisms with the Response to Chemotherapy in Advanced Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Mutational landscape of homologous recombination-related genes in small-cell lung cancer.Semantic proximity Read ↗

Prognostic implication of PD-L1 polymorphisms in non-small cell lung cancer treated with radiotherapy.Semantic proximity Read ↗

Association of genetic polymorphisms in the paraoxonase 1 gene with the risk and prognosis of non-small cell lung cancer in Chinese Han population.Semantic proximity Read ↗

Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung Cancer.Semantic proximity Read ↗

Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.